Manki Chung

Dr. Manki Chung

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
JAJi Hoon Ahn
Ji Hoon Ahn
JKJungMo Kim
JungMo Kim
SHSeon Pyo Hong
Seon Pyo Hong
SCSung Yong Choi
Sung Yong Choi
MYMyung Jin Yang
Myung Jin Yang
GKGou Young Koh
Gou Young Koh
The upper respiratory tract is compromised in the early period of COVID-19, but SARS-CoV-2 tropism at the cellular level is not fully defined. Unlike recent single-cell RNA-Seq analyses indicating uniformly low mRNA expression of SARS-CoV-2 entry–related host molecules in all nasal epithelial cells, we show that the protein levels are relatively high and that their localizations are restricted to the apical side of multiciliated epithelial cells. In addition, we provide evidence in patients with COVID-19 that SARS-CoV-2 is massively detected and replicated within the multiciliated cells. We observed these findings during the early stage of COVID-19, when infected ciliated cells were rapidly replaced by differentiating precursor cells. Moreover, our analyses revealed that SARS-CoV-2 cellular tropism was restricted to the nasal ciliated versus oral squamous epithelium. These results imply that targeting ciliated cells of the nasal epithelium during the early stage of COVID-19 could be an ideal strategy to prevent SARS-CoV-2 propagation.

14 January 2019 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
SMStyliani Melissaridou
Styliani Melissaridou
EWEmilia Wiechec
Emilia Wiechec
MMMustafa Magan
Mustafa Magan
MJMayur Vilas Jain
Mayur Vilas Jain
MCManki Chung
Manki Chung
Karin RobergKarin Roberg
Karin Roberg
Head and Neck Squamous Cell Carcinoma (HNSCC) tumors are often resistant to therapies. Therefore searching for predictive markers and new targets for treatment in clinically relevant in vitro tumor models is essential. Five HNSCC-derived cell lines were used to assess the effect of 3D culturing compared to 2D monolayers in terms of cell proliferation, response to anti-cancer therapy as well as expression of EMT and CSC genes. The viability and proliferation capacity of HNSCC cells as well as induction of apoptosis in tumor spheroids cells after treatment was assessed by MTT assay, crystal violet- and TUNEL assay respectively. Expression of EMT and CSC markers was analyzed on mRNA (RT-qPCR) and protein (Western blot) level. We showed that HNSCC cells from different tumors formed spheroids that differed in size and density in regard to EMT-associated protein expression and culturing time. In all spheroids, an up regulation of CDH1, NANOG and SOX2 was observed in comparison to 2D but changes in the expression of EGFR and EMT markers varied among the cell lines. Moreover, most HNSCC cells grown in 3D showed decreased sensitivity to cisplatin and cetuximab (anti-EGFR) treatment. Taken together, our study points at notable differences between these two cellular systems in terms of EMT-associated gene expression profile and drug response. As the 3D cell cultures imitate the in vivo behaviour of neoplastic cells within the tumor, our study suggest that 3D culture model is superior to 2D monolayers in the search for new therapeutic targets.

31 January 2018 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
MCManki Chung
Manki Chung
YJYoung Ho Jung
Young Ho Jung
JLJoon Kyoo Lee
Joon Kyoo Lee
SCSoo Youn Cho
Soo Youn Cho
OMOihana Murillo-Sauca
Oihana Murillo-Sauca
JSJohn B. Sunwoo
John B. Sunwoo
Purpose: Head and neck squamous cell carcinoma (HNSCC) is comprised of heterogeneous populations of cells, and CD271 (NGFR; p75NTR) has been associated with a tumor-initiating cell subpopulation. This study assessed the role of CD271 in modulating metastatic behavior in HNSCC. Experimental Design: CD271 was overexpressed in murine and human oral squamous cell carcinoma cells to assess the impact of CD271 activation on the invasive and metastatic phenotype of these cells, using in vitro and orthotopic in vivo modeling. Treatment with human nerve growth factor (NGF) to activate CD271, as well as shRNA knockdown of the CD271-upregulated Snai2 expression, was used to assess the mechanism of the CD271-induced invasive phenotype. Relevance of CD271 expression in human HNSCC was evaluated in patient-derived xenografts (PDX) and primary human oral cancers, annotated with clinical behavior characteristics and survival data. Results: Forced expression of CD271 resulted in a more invasive and metastatic phenotype. Slug, an epithelial-to-mesenchymal transition (EMT)-related transcription factor, encoded by Snai2, was highly expressed in MOC2-CD271 and HSC3-CD271, compared with respective parental cells. CD271 activation by NGF conferred enhanced invasiveness in CD271-overexpressing cells, which was abrogated by Snai2 knockdown. In PDXs and primary human HNSCC, CD271 expression correlated with higher Snai2 expression, greater nodal metastasis, and shorter disease-free survival. Conclusions: Activation of CD271 results in upregulation of Snai2/Slug, which, in turn, results in a more invasive phenotype and an enhanced capacity for metastasis to regional lymph nodes. These findings point to CD271 as a promising, therapeutic target for oral cancer metastasis. Clin Cancer Res; 24(3); 674–83. ©2017 AACR.

18 November 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YSYoon Kyoung So
Yoon Kyoung So
SBSun-Ju Byeon
Sun-Ju Byeon
BKBo Mi Ku
Bo Mi Ku
YKYoung Hyeh Ko
Young Hyeh Ko
MAMyung-Ju Ahn
Myung-Ju Ahn
MCManki Chung
Manki Chung
Programmed death-ligand 1 (PD-L1) expression and CD8-positive tumor-infiltrating lymphocyte (CD8+ TIL) infiltration are essential biomarkers for immune checkpoint inhibitor therapy. The objective of this study was to compare the expression of those biomarkers between initial and recurrent HNSCCs using paired analysis. Prognostic significance of those immunological changes was also investigated. Forty-two consecutive patients with locally recurrent HNSCCs were included. Immunohistochemical staining of CD8 and PD-L1 was done for both initial and recurrent tumor specimens. The IHC findings were verified with mRNA expression profiling. Also, the prognostic impact was analyzed based on overall survival (OS). Recurrent-to-initial (R/I) ratios of CD8+ TILs and PD-L1 were widely variable. CD8+ TIL density and PD-L1 expression decreased in 59.5% and 69% of patients, respectively (R/I ratio < 1). The R/I ratio of CD8A mRNA was significantly higher in patients with a CD8 R/I ratio > 1 (1.7 ± 1.5 vs. 0.6 ± 0.6, p = 0.042). CD8 R/I ratio (> 1) was a good prognosticator for OS (HR 0.293, 95% CI 0.091–0.945, p = 0.040). CD8+ TIL infiltration and PD-L1 expression changed variably following local recurrence of HNSCC. The increase of CD8+ TILs at recurrence was an excellent independent prognosticator.

1 April 2017 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
NCN.Y. Choi
N.Y. Choi
EKE.H. Kim
E.H. Kim
CBC.H. Baek
C.H. Baek
ISI. Sohn
I. Sohn
SYS. Yeon
S. Yeon
MCManki Chung
Manki Chung

29 October 2019 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
BKBo Young Kim
Bo Young Kim
NCNayeon Choi
Nayeon Choi
SKSun Wook Kim
Sun Wook Kim
HJHan-Sin Jeong
Han-Sin Jeong
MCManki Chung
Manki Chung
YSYoung-Ik Son
Young-Ik Son